首页> 外文期刊>Kidney and blood pressure research >Angiogenesis in peritoneal dialysis
【24h】

Angiogenesis in peritoneal dialysis

机译:腹膜透析中的血管生成

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Long-term exposure to peritoneal dialysis fluid induces morphological alterations, including angiogenesis, leading to a loss of ultrafiltration (UF) capacity. We discuss the effect of different factors in peritoneal dialysis (PD) on angiogenesis. In addition, we describe the process of angiogenesis and the possible role of different cell types in the peritoneum upon PD contributing to new blood vessel formation. Furthermore, we review several interventions used in our rat PD exposure model to decrease angiogenesis in PD. Moreover, we show new data on the use of sunitinib to inhibit angiogenesis in this rat model. Although various interventions seem to be promising, well-randomised clinical trials showing absolute prevention of angiogenesis and UF failure are, yet, still missing. To make real progress in PD treatment, the aim should be to prevent angiogenesis as well as peritoneal fibrosis and PD-induced inflammation.
机译:长期暴露于腹膜透析液会引起形态学改变,包括血管生成,从而导致超滤(UF)能力丧失。我们讨论腹膜透析(PD)中不同因素对血管生成的影响。此外,我们描述了血管生成的过程以及腹膜上不同细胞类型对PD促成新血管形成的可能作用。此外,我们回顾了大鼠PD暴露模型中用于减少PD血管生成的几种干预措施。此外,我们显示了在该大鼠模型中使用舒尼替尼抑制血管新生的新数据。尽管各种干预措施似乎是有希望的,但随机化的临床试验显示了对血管生成和超滤失败的绝对预防,但仍缺乏。为了使PD治疗取得真正的进展,目标应该是预防血管生成以及腹膜纤维化和PD引起的炎症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号